Clinical Trial Update: A Novel Extracorporeal Liver Support Therapy In ALCF and to Evaluate the Efficacy of DIALIVE 2.0, a Liver Dialysis Device. [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial (NCT07347275) of DIALIVE 2.0, an extracorporeal liver dialysis device, for acute-on-chronic liver failure and liver cirrhosis, is not y…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cirrhosis
• On Chronic Liver Failure

Drugs mentioned

• DIALIVE 2.0

Snippet

Sponsor: Yaqrit Ltd | Conditions: Acute-on-Chronic Liver Failure (ACLF), Liver Cirrhosis | Phase 3 | Status: NOT_YET_RECRUITING